NCT04815031
- Conditions
- COVID-19, Coronaviridae Infections, Coronavirus Infections, +9 more
- Locations
-
- PfizerLocal Country Office Tokyo, Japan
Clinical trial condition
Explore clinical trials studying Respiratory Tract Infections. Study availability and eligibility vary by location and protocol.
NCT04815031
NCT06028347
NCT06457269
NCT04475081
NCT05305443
NCT05472090
NCT06706128
NCT04981392
NCT05813574
NCT06703723